BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23116138)

  • 1. Diffusion, molecular separation, and drug delivery from lipid mesophases with tunable water channels.
    Negrini R; Mezzenga R
    Langmuir; 2012 Nov; 28(47):16455-62. PubMed ID: 23116138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning in-meso-crystallized lysozyme polymorphism by lyotropic liquid crystal symmetry.
    Zabara A; Amar-Yuli I; Mezzenga R
    Langmuir; 2011 May; 27(10):6418-25. PubMed ID: 21506575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oil and drug control the release rate from lyotropic liquid crystals.
    Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
    J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-responsive lyotropic liquid crystals for controlled drug delivery.
    Negrini R; Mezzenga R
    Langmuir; 2011 May; 27(9):5296-303. PubMed ID: 21452814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
    Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
    Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyotropic Cubic Phases for Drug Delivery: Diffusion and Sustained Release from the Mesophase Evaluated by Electrochemical Methods.
    Nazaruk E; Miszta P; Filipek S; Górecka E; Landau EM; Bilewicz R
    Langmuir; 2015 Nov; 31(46):12753-61. PubMed ID: 26513537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the link between self-assembled mesophase structure and drug release.
    Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
    Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.
    Rizwan SB; Boyd BJ; Rades T; Hook S
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1133-44. PubMed ID: 20858165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme Kinetics in Liquid Crystalline Mesophases: Size Matters, But Also Topology.
    Sun W; Vallooran JJ; Mezzenga R
    Langmuir; 2015 Apr; 31(15):4558-65. PubMed ID: 25806598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
    Wu HB; Huo DF; Jiang XG
    Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforated bicontinuous cubic phases with pH-responsive topological channel interconnectivity.
    Zabara A; Negrini R; Onaca-Fischer O; Mezzenga R
    Small; 2013 Nov; 9(21):3602-9. PubMed ID: 23677679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
    Zabara A; Mezzenga R
    J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrostatic swelling of bicontinuous cubic lipid phases.
    Tyler AI; Barriga HM; Parsons ES; McCarthy NL; Ces O; Law RV; Seddon JM; Brooks NJ
    Soft Matter; 2015 Apr; 11(16):3279-86. PubMed ID: 25790335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
    Libster D; Aserin A; Garti N
    J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculations of and evidence for chain packing stress in inverse lyotropic bicontinuous cubic phases.
    Shearman GC; Khoo BJ; Motherwell ML; Brakke KA; Ces O; Conn CE; Seddon JM; Templer RH
    Langmuir; 2007 Jun; 23(13):7276-85. PubMed ID: 17503862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrostatic pressure effects on the lamellar to gyroid cubic phase transition of monolinolein at limited hydration.
    Tang TY; Brooks NJ; Jeworrek C; Ces O; Terrill NJ; Winter R; Templer RH; Seddon JM
    Langmuir; 2012 Sep; 28(36):13018-24. PubMed ID: 22894718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophases.
    Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
    J Phys Chem B; 2014 Jun; 118(23):6277-87. PubMed ID: 24798650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Super-swelled lyotropic single crystals.
    Kim H; Song Z; Leal C
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10834-10839. PubMed ID: 28973884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules.
    Bisset NB; Boyd BJ; Dong YD
    Int J Pharm; 2015 Nov; 495(1):241-248. PubMed ID: 26319637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.